128 related articles for article (PubMed ID: 25142529)
1. No association between NRG1 and ErbB4 genes and psychopathological symptoms of schizophrenia.
Tosato S; Zanoni M; Bonetto C; Tozzi F; Francks C; Ira E; Tomassi S; Bertani M; Rujescu D; Giegling I; St Clair D; Tansella M; Ruggeri M; Muglia P
Neuromolecular Med; 2014 Dec; 16(4):742-51. PubMed ID: 25142529
[TBL] [Abstract][Full Text] [Related]
2. Biological validation of increased schizophrenia risk with NRG1, ERBB4, and AKT1 epistasis via functional neuroimaging in healthy controls.
Nicodemus KK; Law AJ; Radulescu E; Luna A; Kolachana B; Vakkalanka R; Rujescu D; Giegling I; Straub RE; McGee K; Gold B; Dean M; Muglia P; Callicott JH; Tan HY; Weinberger DR
Arch Gen Psychiatry; 2010 Oct; 67(10):991-1001. PubMed ID: 20921115
[TBL] [Abstract][Full Text] [Related]
3. Evidence that interaction between neuregulin 1 and its receptor erbB4 increases susceptibility to schizophrenia.
Norton N; Moskvina V; Morris DW; Bray NJ; Zammit S; Williams NM; Williams HJ; Preece AC; Dwyer S; Wilkinson JC; Spurlock G; Kirov G; Buckland P; Waddington JL; Gill M; Corvin AP; Owen MJ; O'Donovan MC
Am J Med Genet B Neuropsychiatr Genet; 2006 Jan; 141B(1):96-101. PubMed ID: 16249994
[TBL] [Abstract][Full Text] [Related]
4. Genetic study of neuregulin 1 and receptor tyrosine-protein kinase erbB-4 in tardive dyskinesia.
Zai CC; Tiwari AK; Chowdhury NI; Yilmaz Z; de Luca V; Müller DJ; Potkin SG; Lieberman JA; Meltzer HY; Voineskos AN; Remington G; Kennedy JL
World J Biol Psychiatry; 2019 Jan; 20(1):91-95. PubMed ID: 28394697
[TBL] [Abstract][Full Text] [Related]
5. Large-scale candidate gene study to identify genetic risk factors predictive of paliperidone treatment response in patients with schizophrenia.
Wang D; Fu DJ; Wu X; Shapiro A; Favis R; Savitz A; Chung H; Alphs L; Gopal S; Haas M; Cohen N; Li Q
Pharmacogenet Genomics; 2015 Apr; 25(4):173-85. PubMed ID: 25714000
[TBL] [Abstract][Full Text] [Related]
6. Discovery, validation and characterization of Erbb4 and Nrg1 haplotypes using data from three genome-wide association studies of schizophrenia.
Agim ZS; Esendal M; Briollais L; Uyan O; Meschian M; Martinez LA; Ding Y; Basak AN; Ozcelik H
PLoS One; 2013; 8(1):e53042. PubMed ID: 23301017
[TBL] [Abstract][Full Text] [Related]
7. Behavioral, Neurophysiological, and Synaptic Impairment in a Transgenic Neuregulin1 (NRG1-IV) Murine Schizophrenia Model.
Papaleo F; Yang F; Paterson C; Palumbo S; Carr GV; Wang Y; Floyd K; Huang W; Thomas CJ; Chen J; Weinberger DR; Law AJ
J Neurosci; 2016 Apr; 36(17):4859-75. PubMed ID: 27122041
[TBL] [Abstract][Full Text] [Related]
8. Neuregulin-1 signalling and antipsychotic treatment: potential therapeutic targets in a schizophrenia candidate signalling pathway.
Deng C; Pan B; Engel M; Huang XF
Psychopharmacology (Berl); 2013 Mar; 226(2):201-15. PubMed ID: 23389757
[TBL] [Abstract][Full Text] [Related]
9. Antipsychotic treatment and neuregulin 1-ErbB4 signalling in schizophrenia.
Pan B; Huang XF; Deng C
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):924-30. PubMed ID: 21513767
[TBL] [Abstract][Full Text] [Related]
10. Epistatic interactions of NRG1 and ERBB4 on antipsychotic treatment response in first-episode schizophrenia patients.
Zhang Y; Zhang CY; Yuan J; Zeng XZ; Zhai SS; Xiao X; Li M; Yang JZ
Schizophr Res; 2022 Mar; 241():197-200. PubMed ID: 35144058
[No Abstract] [Full Text] [Related]
11. Elevated neuregulin-1 and ErbB4 protein in the prefrontal cortex of schizophrenic patients.
Chong VZ; Thompson M; Beltaifa S; Webster MJ; Law AJ; Weickert CS
Schizophr Res; 2008 Mar; 100(1-3):270-80. PubMed ID: 18243664
[TBL] [Abstract][Full Text] [Related]
12. Association and interaction analyses of NRG1 and ERBB4 genes with schizophrenia in a Japanese population.
Shiota S; Tochigi M; Shimada H; Ohashi J; Kasai K; Kato N; Tokunaga K; Sasaki T
J Hum Genet; 2008; 53(10):929-935. PubMed ID: 18704261
[TBL] [Abstract][Full Text] [Related]
13. Molecular dissection of NRG1-ERBB4 signaling implicates PTPRZ1 as a potential schizophrenia susceptibility gene.
Buxbaum JD; Georgieva L; Young JJ; Plescia C; Kajiwara Y; Jiang Y; Moskvina V; Norton N; Peirce T; Williams H; Craddock NJ; Carroll L; Corfas G; Davis KL; Owen MJ; Harroch S; Sakurai T; O'Donovan MC
Mol Psychiatry; 2008 Feb; 13(2):162-72. PubMed ID: 17579610
[TBL] [Abstract][Full Text] [Related]
14. Analysis of association between common SNPs in ErbB4 and bipolar affective disorder, major depressive disorder and schizophrenia in the Han Chinese population.
Chen P; Chen J; Huang K; Ji W; Wang T; Li T; Wang Y; Wang H; He L; Feng G; Shi Y
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Jan; 36(1):17-21. PubMed ID: 21993442
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of short- and long-term antipsychotic treatment on the expression of neuregulin-1 and ErbB4 receptors in the rat brain.
Deng C; Pan B; Hu CH; Han M; Huang XF
Psychiatry Res; 2015 Feb; 225(3):347-54. PubMed ID: 25576368
[TBL] [Abstract][Full Text] [Related]
16. Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia.
Hahn CG; Wang HY; Cho DS; Talbot K; Gur RE; Berrettini WH; Bakshi K; Kamins J; Borgmann-Winter KE; Siegel SJ; Gallop RJ; Arnold SE
Nat Med; 2006 Jul; 12(7):824-8. PubMed ID: 16767099
[TBL] [Abstract][Full Text] [Related]
17. Neuregulin 1-ErbB4-PI3K signaling in schizophrenia and phosphoinositide 3-kinase-p110δ inhibition as a potential therapeutic strategy.
Law AJ; Wang Y; Sei Y; O'Donnell P; Piantadosi P; Papaleo F; Straub RE; Huang W; Thomas CJ; Vakkalanka R; Besterman AD; Lipska BK; Hyde TM; Harrison PJ; Kleinman JE; Weinberger DR
Proc Natl Acad Sci U S A; 2012 Jul; 109(30):12165-70. PubMed ID: 22689948
[TBL] [Abstract][Full Text] [Related]
18. A neuregulin 1 transmembrane domain mutation causes imbalanced glutamatergic and dopaminergic receptor expression in mice.
Newell KA; Karl T; Huang XF
Neuroscience; 2013 Sep; 248():670-80. PubMed ID: 23811072
[TBL] [Abstract][Full Text] [Related]
19. Interactions among genes in the ErbB-Neuregulin signalling network are associated with increased susceptibility to schizophrenia.
Benzel I; Bansal A; Browning BL; Galwey NW; Maycox PR; McGinnis R; Smart D; St Clair D; Yates P; Purvis I
Behav Brain Funct; 2007 Jun; 3():31. PubMed ID: 17598910
[TBL] [Abstract][Full Text] [Related]
20. The involvement of ErbB4 with schizophrenia: association and expression studies.
Silberberg G; Darvasi A; Pinkas-Kramarski R; Navon R
Am J Med Genet B Neuropsychiatr Genet; 2006 Mar; 141B(2):142-8. PubMed ID: 16402353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
